Abstract：Objective To investigate the trends in incidence and mortality of prostate cancer in Wenzhou City, Zhejiang Province from 2015 to 2024, so as to provide evidence for optimizing prostate cancer prevention and control measures. Methods Data concerning the incidence and mortality of prostate cancer cases from 2015 to 2024 were collected through the Wenzhou Chronic Disease Collaborative Management System. The crude incidence and crude mortality were calculated. Standardized incidence and standardized mortality were computed on the basis of the age distribution data of the standard population from the Fifth National Population Census in 2000. The average annual percent change (AAPC) was used to analyze the trends in prostate cancer incidence and mortality across different regions and age groups. Results From 2015 to 2024, the crude incidence (AAPC=13.905%, 11.076% and 14.915%) and standardized incidence (AAPC=10.053%, 7.720% and 10.901%) of prostate cancer presented increasing trends in the whole city, urban and rural areas (all P<0.05). The crude mortality kept increasing across the three regions (AAPC=10.003%, 9.038% and 10.272%, all P<0.05). Rising standardized mortality was detected in the whole city and rural areas (AAPC=4.307%, 4.762%, both P<0.05), whereas the urban areas standardized mortality trend was not statistically significant (AAPC=2.637%, P>0.05). The crude incidence and mortality rose with advancing age (both P<0.05) and reached peak values of 241.65/105 and 139.30/105 within the group aged ≥80?years. The 60-<70 years old group had the fastest growing crude incidence for the whole city and rural areas (AAPC=13.675%, 15.081%, both P<0.05), and the maximum growth rate appeared in the 50-<60 years old group in urban areas (AAPC=11.880%, P<0.05). The ≥80 years old group exhibited the most rapid increase of crude mortality in all areas (AAPC=10.815%, 10.073% and 10.956%, all P<0.05). Conclusions The incidence and mortality of prostate cancer increased in Wenzhou City from 2015 to 2024, with a relatively rapid upward tendency in rural areas. Particular attention should be paid to enhancing screening coverage and treatment accessibility for prostate cancer in middle-aged and elderly males.
姜雪霞, 樊丽辉, 郑宇航, 罗永园, 李慧君, 夏喆铮, 叶振淼. 2015—2024年温州市前列腺癌发病和死亡趋势分析[J]. 预防医学, 2026, 38(8): 776-780.
JIANG Xuexia, FAN Lihui, ZHENG Yuhang, LUO Yongyuan, LI Huijun, XIA Zhezheng, YE Zhenmiao. Trends in incidence and mortality of prostate cancer in Wenzhou City from 2015 to 2024. Preventive Medicine, 2026, 38(8): 776-780.
[1] Bray F,Laversanne M,Sung H,et al.Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2024,74(3):229-263. [2] 瞿旻,高旭.2022年全球及中国前列腺癌流行状况分析[J].海军军医大学学报,2025,46(2):229-233. [3] 林豪胜,杨增士,叶宁.基于年龄-时期-队列模型的中国前列腺癌发病死亡趋势分析[J].临床泌尿外科杂志,2024,39(8):708-712. [4] 陈铭睿,林玲,楚楚,等.2013—2022年南通市结直肠癌发病和死亡趋势分析[J].预防医学,2025,37(10):1039-1044. [5] 郑荣寿,陈茹,韩冰峰,等.2022年中国恶性肿瘤流行情况分析[J].中华肿瘤杂志,2024,46(3):221-231. [6] 章群,王永,陈洁平,等.2011—2023年宁波市前列腺癌发病和死亡趋势分析[J].预防医学,2025,37(1):46-50. [7] 华天齐,褚叶琳,徐文超,等.2011—2021年常州市前列腺癌发病与死亡的年龄变化趋势及预测分析[J].实用肿瘤学杂志,2026,40(1):9-15. [8] 王丹,邹雪平,成姝雯,等.2015—2019年四川省肿瘤登记地区前列腺癌流行特征及早死疾病负担趋势分析[J].中国肿瘤,2024,33(9):709-715. [9] 张国英,孙琦,赵帅,等.2014—2023年山东省威海市恶性肿瘤发病和死亡流行特征及变化趋势[J].中华肿瘤防治杂志,2025,32(21):1275-1282. [10] 蔡红霞,尹若云,钱蒙,等.1992—2021年中国前列腺癌发病与死亡年龄-时期-队列及灰色预测分析[J].中国循证医学杂志,2025,25(7):768-774. [11] 赫捷,魏文强.2022中国肿瘤登记年报[M].北京:人民卫生出版社,2025. [12] Zhou C K,Check D P,Lortet-Tieulent J,et al.Prostate cancer incidence in 43 populations worldwide:an analysis of time trends overall and by age group[J].Int J Cancer,2016,138(6):1388-1400. [13] 赵俊峰,何丽华,李为翊,等.2002—2019年黄浦区前列腺癌发病和死亡趋势[J].预防医学,2024,36(10):878-881,886. [14] 陈梦倩,王小红,周凡,等.2016—2024年金华市前列腺癌发病和死亡趋势分析[J].预防医学,2025,37(10):1035-1038. [15] 邹博,龙衍,杨智明,等.湖南地区前列腺癌流行病学及临床病理特征分析[J].中华男科学杂志,2022,28(9):786-791.
